Advanced biomedical materials and drug delivery systems for gastrointestinal applications: current understanding and future perspectives

Abstract The gastrointestinal (GI) tract is a major site of ulcerative, inflammatory, and neoplastic diseases. It also functions as an important interface in systemic metabolic regulation. The effectiveness of current treatments is often limited by poor drug stability and short residence times in the GI tract, insufficient exposure at the target site, and unnecessary systemic exposure. These limitations are compounded by regional pH changes, digestive enzymes, mucus turnover, peristaltic clearance, immune surveillance, and microbial metabolism. Advanced biomedical materials, including mucoadhesive hydrogels, stimuli-responsive nanoplatforms, metal–organic frameworks (MOFs), and extracellular matrix (ECM)-derived scaffolds, are increasingly being developed to protect cargo, prolong mucosal residence, enable site-selective release, support tissue repair, and modulate immune or microbial processes. However, selecting a suitable material and delivery strategy for different GI diseases remains challenging. This review examines physiological barriers to drug delivery in the GI tract, classifies advanced biomaterials and delivery systems by therapeutic function and platform type, and evaluates their applications across GI diseases with attention to administration routes, target sites, therapeutic outcomes, and clinical translation. Finally, we discuss future priorities for route-specific material design, human-relevant evaluation, and the safe development of advanced delivery systems. This review aims to provide a practical reference for selecting appropriate biomaterials and delivery systems for GI disease treatment and for guiding their further development toward clinical use.

Authors

Publication Details

Journal
Molecular Biomedicine
Published
2026-11-13
DOI
https://doi.org/10.1186/s43556-026-00654-7
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Advanced biomedical materials and drug delivery systems for gastrointestinal applications: current understanding and future perspectives

Feng Wang, Rongkang Huang, Zixin Chen, Yijie Hu et al.
Molecular Biomedicine
Advanced Drug Delivery Systems
article

Advanced biomedical materials and drug delivery systems for gastrointestinal applications: current understanding and future perspectives

Feng Wang, Rongkang Huang, Zixin Chen, Yijie Hu, Shengjie Luo, Yong Li, Jian Cai
article en

Abstract

Abstract The gastrointestinal (GI) tract is a major site of ulcerative, inflammatory, and neoplastic diseases. It also functions as an important interface in systemic metabolic regulation. The effectiveness of current treatments is often limited by poor drug stability and short residence times in the GI tract, insufficient exposure at the target site, and unnecessary systemic exposure. These limitations are compounded by regional pH changes, digestive enzymes, mucus turnover, peristaltic clearance, immune surveillance, and microbial metabolism. Advanced biomedical materials, including mucoadhesive hydrogels, stimuli-responsive nanoplatforms, metal–organic frameworks (MOFs), and extracellular matrix (ECM)-derived scaffolds, are increasingly being developed to protect cargo, prolong mucosal residence, enable site-selective release, support tissue repair, and modulate immune or microbial processes. However, selecting a suitable material and delivery strategy for different GI diseases remains challenging. This review examines physiological barriers to drug delivery in the GI tract, classifies advanced biomaterials and delivery systems by therapeutic function and platform type, and evaluates their applications across GI diseases with attention to administration routes, target sites, therapeutic outcomes, and clinical translation. Finally, we discuss future priorities for route-specific material design, human-relevant evaluation, and the safe development of advanced delivery systems. This review aims to provide a practical reference for selecting appropriate biomaterials and delivery systems for GI disease treatment and for guiding their further development toward clinical use.

Molecular BiomedicineVol. 7(1)
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon